20/20 Biolabs, Inc Common Stock
Quarterly Financials
| Values in thousands | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $353 | $538 | $417 | $553 |
Gross Profit | 62 | 130 | 145 | 165 |
EBITDA | -1,434 | -780 | ||
EBIT | -1,443 | -800 | ||
Net Income | -2,120 | -1,307 | -825 | -764 |
Net Change In Cash | 353 | 538 | 417 | 553 |
Free Cash Flow | -1,288 | -511 | -488 | |
Cash | 4,219 | 1,025,987 | 1,144 | |
Basic Shares | 7,657 | 10,347 | 4,856 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $2,045 | $1,752 | $1,424 | $11,059 |
Gross Profit | 604 | 360 | 109 | 5,121 |
EBITDA | -3,330 | -5,525 | -6,194 | 1,967 |
EBIT | -5,661 | -6,361 | 1,678 | |
Net Income | -3,738 | -5,551 | -6,391 | 2,186 |
Net Change In Cash | 2,045 | 1,752 | 1,424 | 11,059 |
Free Cash Flow | -1,919,720 | -2,598 | -4,637 | 5,541 |
Cash | 1,025,987 | 1,784 | 4,089 | 8,807 |
Basic Shares | 6,256 | 4,800 | 4,768 | 9,487 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | -$0.28 |
2025-12-31 | -$0.12 |